Literature DB >> 22146689

The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract.

T A Tompkins1, I Mainville, Y Arcand.   

Abstract

Commercial literature on various probiotic products suggests that they can be taken before meals, during meals or after meals or even without meals. This has led to serious confusion for the industry and the consumer. The objective of our study was to examine the impact of the time of administration with respect to mealtime and the impact of the buffering capacity of the food on the survival of probiotic microbes during gastrointestinal transit. We used an in vitro Digestive System (IViDiS) model of the upper gastrointestinal tract to examine the survival of a commercial multi-strain probiotic, ProtecFlor®. This product, in a capsule form, contains four different microbes: two lactobacilli (Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011), Bifidobacterium longum R0175 and Saccharomyces cerevisiae boulardii. Enumeration during and after transit of the stomach and duodenal models showed that survival of all the bacteria in the product was best when given with a meal or 30 minutes before a meal (cooked oatmeal with milk). Probiotics given 30 minutes after the meal did not survive in high numbers. Survival in milk with 1% milk fat and oatmeal-milk gruel were significantly better than apple juice or spring water. S. boulardii was not affected by time of meal or the buffering capacity of the meal. The protein content of the meal was probably not as important for the survival of the bacteria as the fat content. We conclude that ideally, non-enteric coated bacterial probiotic products should be taken with or just prior to a meal containing some fats.

Entities:  

Mesh:

Year:  2011        PMID: 22146689     DOI: 10.3920/BM2011.0022

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  7 in total

Review 1.  International Society of Sports Nutrition Position Stand: Probiotics.

Authors:  Ralf Jäger; Alex E Mohr; Katie C Carpenter; Chad M Kerksick; Martin Purpura; Adel Moussa; Jeremy R Townsend; Manfred Lamprecht; Nicholas P West; Katherine Black; Michael Gleeson; David B Pyne; Shawn D Wells; Shawn M Arent; Abbie E Smith-Ryan; Richard B Kreider; Bill I Campbell; Laurent Bannock; Jonathan Scheiman; Craig J Wissent; Marco Pane; Douglas S Kalman; Jamie N Pugh; Jessica A Ter Haar; Jose Antonio
Journal:  J Int Soc Sports Nutr       Date:  2019-12-21       Impact factor: 5.150

2.  Dissolution of Lipid-Based Matrices in Simulated Gastrointestinal Solutions to Evaluate Their Potential for the Encapsulation of Bioactive Ingredients for Foods.

Authors:  Yves Raymond; Claude P Champagne
Journal:  Int J Food Sci       Date:  2014-06-12

3.  Multifunctional Role of the Whey Culture Medium in the Spray Drying Microencapsulation of Lactic Acid Bacteria.

Authors:  Stephania Aragón-Rojas; María Ximena Quintanilla-Carvajal; Humberto Hernández-Sánchez
Journal:  Food Technol Biotechnol       Date:  2018-09       Impact factor: 3.918

4.  Knowledge, attitudes, and understanding of probiotics among pediatricians in different regions of Saudi Arabia.

Authors:  Mohammed Hasosah; Mansour Qurashi; Abdullah Balkhair; Ziyad Alzahrani; Abdullah Alabbasi; Muhanad Alzahrani; Wejdan Alnahdi; Sohaib Shafei; Malak Bafaqih; Muhammad Khan
Journal:  BMC Med Educ       Date:  2021-01-21       Impact factor: 2.463

Review 5.  Targeted Delivery of Probiotics: Perspectives on Research and Commercialization.

Authors:  K S Yoha; Sundus Nida; Sayantani Dutta; J A Moses; C Anandharamakrishnan
Journal:  Probiotics Antimicrob Proteins       Date:  2021-04-27       Impact factor: 5.265

6.  Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial.

Authors:  Joanna Harnett; Stephen P Myers; Margaret Rolfe
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-21       Impact factor: 2.629

7.  Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial.

Authors:  Leila Khalili; Beitullah Alipour; Mohammad Asghari Jafarabadi; Tohid Hassanalilou; Mehran Mesgari Abbasi; Ismail Faraji
Journal:  Diabetol Metab Syndr       Date:  2019-01-15       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.